{"id":"https://openalex.org/W2332237372","doi":"https://doi.org/10.2146/news130023","title":"Ado-trastuzumab emtansine approved for advanced breast cancer","display_name":"Ado-trastuzumab emtansine approved for advanced breast cancer","publication_year":2013,"publication_date":"2013-03-20","ids":{"openalex":"https://openalex.org/W2332237372","doi":"https://doi.org/10.2146/news130023","mag":"2332237372","pmid":"https://pubmed.ncbi.nlm.nih.gov/23515502"},"language":"en","primary_location":{"id":"doi:10.2146/news130023","doi":"https://doi.org/10.2146/news130023","is_oa":false,"landing_page_url":"https://doi.org/10.2146/news130023","pdf_url":null,"source":{"id":"https://openalex.org/S105051383","display_name":"American Journal of Health-System Pharmacy","issn_l":"1079-2082","issn":["1079-2082","1535-2900"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Health-System Pharmacy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103950175","display_name":"Kate Traynor","orcid":"https://orcid.org/0009-0008-7574-2486","observed_orcids":["https://orcid.org/0009-0008-7574-2486"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kate Traynor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5103950175"],"corresponding_institution_ids":[],"apc_list":{"value":4448,"currency":"USD","value_usd":4448},"apc_paid":null,"fwci":1.0707,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.78351868,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"70","issue":"7","first_page":"562","last_page":"562"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab-emtansine","display_name":"trastuzumab emtansine","score":1.0},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8180000185966492},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9559999704360962},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9309999942779541},{"id":"https://openalex.org/keywords/dm1","display_name":"DM1","score":0.8880000114440918},{"id":"https://openalex.org/keywords/microtubule-inhibitors","display_name":"microtubule inhibitors","score":0.8309999704360962},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.7360000014305115},{"id":"https://openalex.org/keywords/boxed-warning","display_name":"black box warning","score":0.628000020980835},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6179999709129333}],"concepts":[{"id":"https://openalex.org/C2778087150","wikidata":"https://www.wikidata.org/wiki/Q3997863","display_name":"Trastuzumab emtansine","level":5,"score":0.8823242783546448},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7275172472000122},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.6925384402275085},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5430538058280945},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.517859697341919},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4000139832496643},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3858509361743927}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000080044","descriptor_name":"Ado-Trastuzumab Emtansine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2146/news130023","doi":"https://doi.org/10.2146/news130023","is_oa":false,"landing_page_url":"https://doi.org/10.2146/news130023","pdf_url":null,"source":{"id":"https://openalex.org/S105051383","display_name":"American Journal of Health-System Pharmacy","issn_l":"1079-2082","issn":["1079-2082","1535-2900"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Health-System Pharmacy","raw_type":"journal-article"},{"id":"pmid:23515502","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23515502","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","raw_type":"News"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2318714176","https://openalex.org/W2012318088","https://openalex.org/W2093215461","https://openalex.org/W4243119661","https://openalex.org/W2000714108","https://openalex.org/W2099797203","https://openalex.org/W4231552424","https://openalex.org/W2095128045","https://openalex.org/W2129344486","https://openalex.org/W3013445138"],"abstract_inverted_index":{"FDA":[0],"and":[1,93,139,162],"Genentech":[2],"on":[3],"February":[4],"22":[5],"announced":[6],"the":[7,17,34,43,55,64,146,152],"approval":[8],"of":[9,19,54],"ado-trastuzumab":[10,115],"emtansine,":[11],"an":[12],"antibody\u2013":[13],"drug":[14,35,65,141],"conjugate,":[15],"for":[16,48,85,100,137,145],"treatment":[18],"human":[20],"epidermal":[21],"growth":[22],"factor":[23],"receptor":[24],"2":[25],"(HER2)-positive":[26],"metastatic":[27,102],"breast":[28,103],"cancer.":[29,104],"Genentech\u2019s":[30],"announcement":[31],"stated":[32],"that":[33,51,169],"would":[36],"be":[37,143],"available":[38],"within":[39],"two":[40],"weeks":[41],"under":[42],"brand":[44],"name":[45],"Kadcycla.":[46],"Labeling":[47],"Kadcycla":[49],"states":[50],"it":[52],"consists":[53],"humanized":[56],"anti-HER2":[57],"monoclonal":[58],"antibody":[59,73],"trastuzumab":[60,92],"covalently":[61],"linked":[62,76],"to":[63,77],"DM1,":[66],"a":[67,94,135],"microtubule":[68],"inhibitor.":[69],"On":[70],"average,":[71],"each":[72],"molecule":[74],"is":[75,83,133],"3.5":[78],"DM1":[79],"molecules.":[80],"Ado-trastuzumab":[81],"emtansine":[82,116],"indicated":[84],"use":[86],"in":[87,98,109,123,151],"patients":[88,124],"previously":[89],"treated":[90,113,125],"with":[91,114,126],"taxane,":[95],"separately":[96],"or":[97],"combination,":[99],"HER2-positive":[101],"The":[105,130],"median":[106],"survival":[107],"time":[108],"clinical":[110],"trial":[111],"participants":[112],"was":[117],"about":[118],"six":[119],"months":[120],"longer":[121],"than":[122],"lapatinib":[127],"plus":[128],"capecitabine.":[129],"conjugated":[131],"therapy":[132],"not":[134],"replacement":[136],"trastuzumab,":[138],"neither":[140],"should":[142],"substituted":[144],"other.":[147],"A":[148],"boxed":[149],"warning":[150],"drug\u2019s":[153],"labeling":[154],"cites":[155],"impaired":[156],"heart":[157],"function,":[158],"liver":[159],"failure,":[160],"death,":[161],"fetal":[163],"harm":[164],"as":[165],"serious":[166],"adverse":[167],"events":[168],"may":[170],"occur":[171],"during":[172],"therapy.":[173]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}